Skip to main content
main-content

Hyperglycemia


Browse the latest news, expert commentary, and educational content on hyperglycemia.


Highlights

Syringe and pills

11-01-2022 | SGLT2 inhibitors | News

Real-world adjunctive medication outcomes in type 1 diabetes revealed

People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.

Healthy breakfast - symbolic image with model

07-21-2022 | Sotagliflozin | News

Sotagliflozin effects differ from empagliflozin only at breakfast

The only notable short-term differences in the effects of sotagliflozin and empagliflozin occur in glucose metabolism after breakfast, show findings from a randomized trial.

Diabetes and pregnancy_AdobeStock_158940533

06-28-2022 | Pregnancy | News

CGM data highlight need for early glucose control in type 1 diabetes pregnancies

Continuous glucose monitoring metrics show early divergence between pregnant women with type 1 diabetes who subsequently give birth to normal weight versus large for gestational age infants, study findings indicate.

Featured contributor

Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust, UK. 

In this featured article, Prof. Heller explains why time-in-range targets are so helpful for people with diabetes… yet handing out continuous glucose monitoring devices willy-nilly could do more harm than good.

Read the article